Source:http://linkedlifedata.com/resource/pubmed/id/17703413
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2007-8-17
|
pubmed:abstractText |
The innate immune system mounts the first host response to pathogens. Because alpha-defensins, which are cationic antimicrobial peptides of polymorphonuclear neutrophils and other leukocytes, are important effectors of the innate immune system, we studied the antiviral activity of human alpha-defensin-1 (also known as "human neutrophil peptide-1" [HNP-1]) against influenza virus in vitro. Treatment of cell cultures with HNP-1 soon after infection resulted in marked inhibition of influenza virus replication and viral protein synthesis. This effect was not due to cytotoxicity or to a direct effect on the virus. Treatment of cells with HNP-1 followed by its removal before infection also inhibited viral replication, suggesting that the inhibition was due to the modulation of cellular pathways. HNP-1 treatment inhibited protein kinase C (PKC) activation in infected cells, suggesting the involvement of the PKC pathway. Our data expand the previously known activity of alpha -defensins against influenza virus. Characterizing the mechanism of action of alpha -defensins may lead to the identification of new strategies for prevention and therapy.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-Defensins,
http://linkedlifedata.com/resource/pubmed/chemical/human neutrophil peptide 1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-1899
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
196
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
835-43
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17703413-Animals,
pubmed-meshheading:17703413-Antiviral Agents,
pubmed-meshheading:17703413-Cattle,
pubmed-meshheading:17703413-Cell Line,
pubmed-meshheading:17703413-Dogs,
pubmed-meshheading:17703413-Humans,
pubmed-meshheading:17703413-Influenza A virus,
pubmed-meshheading:17703413-Protein Kinase C,
pubmed-meshheading:17703413-Signal Transduction,
pubmed-meshheading:17703413-Viral Proteins,
pubmed-meshheading:17703413-Virus Replication,
pubmed-meshheading:17703413-alpha-Defensins
|
pubmed:year |
2007
|
pubmed:articleTitle |
alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s).
|
pubmed:affiliation |
Division of Infectious Diseases, Mount Sinai School of Medicine, New York, NY 100129, USA. Mirella.Salvatore@mssm.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|